儿童颈部单中心型Castleman病的临床病理特点分析

毕先云, 黄锐, 明澄, 等. 儿童颈部单中心型Castleman病的临床病理特点分析[J]. 临床耳鼻咽喉头颈外科杂志, 2024, 38(8): 732-736. doi: 10.13201/j.issn.2096-7993.2024.08.011
引用本文: 毕先云, 黄锐, 明澄, 等. 儿童颈部单中心型Castleman病的临床病理特点分析[J]. 临床耳鼻咽喉头颈外科杂志, 2024, 38(8): 732-736. doi: 10.13201/j.issn.2096-7993.2024.08.011
BI Xianyun, HUANG Rui, MING Cheng, et al. The clinicopathologic features of unicentric Castleman disease in the children's neck[J]. J Clin Otorhinolaryngol Head Neck Surg, 2024, 38(8): 732-736. doi: 10.13201/j.issn.2096-7993.2024.08.011
Citation: BI Xianyun, HUANG Rui, MING Cheng, et al. The clinicopathologic features of unicentric Castleman disease in the children's neck[J]. J Clin Otorhinolaryngol Head Neck Surg, 2024, 38(8): 732-736. doi: 10.13201/j.issn.2096-7993.2024.08.011

儿童颈部单中心型Castleman病的临床病理特点分析

详细信息
    通讯作者: 马静,E-mail: majing@etyy.cn
  • 中图分类号: R739.91

The clinicopathologic features of unicentric Castleman disease in the children's neck

More Information
  • 目的 探讨儿童颈部单中心型Castleman病的临床特点、影像学表现、病理表型、治疗和预后,以期提高耳鼻咽喉头颈外科医师对Castleman病的认识。方法 回顾性横断面分析2015年7月-2020年6月在昆明市儿童医院经病理诊断为Castleman病、肿物在颈部的6例患儿临床资料,总结其影像学和病理特征,探讨其发生机制。结果 6例Castleman病患儿中,男5例,女1例。组织病理学:透明血管型5例,混合型1例。透明血管型中观察到一致的病理特征是:萎缩的生发中心伴淋巴细胞削减、增生的套细胞呈同心圆状排列、大量的血管增生,且在滤泡间区高内皮小静脉的增生占据主导地位。2例患儿表现出生发中心双胞胎/花椰菜形多胞胎的同时,观察到“棒棒糖”外观的形成。所有患儿均接受了病灶完整手术切除治疗,随访中位时间48(26,84)个月,预后良好。结论 儿童颈部单中心型Castleman病大多数延迟确诊,多表现为无痛性淋巴结肿大,病理类型以透明血管型为主,外科手术治疗整体预后良好。
  • 加载中
  • 图 1  CD的影像学表现

    图 2  CD的病理学特征

    表 1  6例UCD患儿的临床资料

    编号 性别 年龄 病史/月 肿块部位 肿块大小/cm2 CT值/HU 病理类型
    1 9岁3个月 24 左颈Ⅲ~Ⅴ区 2.4×1.9 46 HV-CD
    2 10岁6个月 36 右颈Ⅴ~Ⅵ区 3.0×2.9 55 HV-CD
    3 10岁5个月 6 左颈Ⅲ区 2.1×5.3 49 HV-CD
    4 7岁6个月 12 左颈Ⅴ区 1.7×2.3 53 HV-CD
    5 15岁7个月 1 左颈Ⅲ~Ⅴ区 4.3×2.7 51 HV-CD
    6 4岁 24 右颈Ⅱ~Ⅲ区 2.9×3.7 42 MT-CD
    下载: 导出CSV
  • [1]

    Fajgenbaum DC, Uldrick TS, Bagg A, et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease[J]. Blood, 2017, 129(12): 1646-1657. doi: 10.1182/blood-2016-10-746933

    [2]

    van Rhee F, Voorhees P, Dispenzieri A, et al. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease[J]. Blood, 2018, 132(20): 2115-2124. doi: 10.1182/blood-2018-07-862334

    [3]

    van Rhee F, Oksenhendler E, Srkalovic G, et al. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease[J]. Blood Adv, 2020, 4(23): 6039-6050. doi: 10.1182/bloodadvances.2020003334

    [4]

    Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease[J]. Blood, 2020, 135(16): 1353-1364. doi: 10.1182/blood.2019000931

    [5]

    孟庆磊, 李白, 王一铭, 等. 儿童Castleman病临床病理和治疗分析[J]. 中华儿科杂志, 2022, 60(3): 227-231.

    [6]

    Dong Y, Na J, Lv J, et al. Clinical and laboratory characterization of a large cohort of patients with Castleman disease retrospectively collected from a single center[J]. Leuk Lymphoma, 2009, 50(8): 1308-1317. doi: 10.1080/10428190903060095

    [7]

    中华医学会血液学分会淋巴细胞疾病学组, 中国抗癌协会血液肿瘤专业委员会, 中国Castleman病协作组. 中国Castleman病诊断与治疗专家共识(2021年版)[J]. 中华血液学杂志, 2021, 42(7): 529-534. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWWK202107001.htm

    [8]

    Dong Y, Wang M, Nong L, et al. Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single centre: paraneoplastic pemphigus is an unfavourable prognostic factor[J]. Br J Haematol, 2015, 169(6): 834-842. doi: 10.1111/bjh.13378

    [9]

    Zhang MY, Jia MN, Chen J, et al. UCD with MCD-like inflammatory state: surgical excision is highly effective[J]. Blood Adv, 2021, 5(1): 122-128.

    [10]

    Nishi J, Maruyama I. Increased expression of vascular endothelial growth factor(VEGF)in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node[J]. Leuk Lymphoma, 2000, 38(3-4): 387-394. doi: 10.3109/10428190009087030

    [11]

    Carbone A, Borok M, Damania B, et al. Castleman disease[J]. Nat Rev Dis Primers, 2021, 7(1): 84. doi: 10.1038/s41572-021-00317-7

    [12]

    Nishi J, Arimura K, Utsunomiya A, et al. Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease[J]. Br J Haematol, 1999, 104(3): 482-485. doi: 10.1046/j.1365-2141.1999.01208.x

    [13]

    Rabinowitz MR, Levi J, Conard K, et al. Castleman disease in the pediatric neck: a literature review[J]. Otolaryngol Head Neck Surg, 2013, 148(6): 1028-1036. doi: 10.1177/0194599813479931

    [14]

    刘丁丁, 孙飞虎, 魏浩, 等. 首发于头颈部的Castleman病临床特征分析[J]. 临床耳鼻咽喉头颈外科杂志, 2022, 36(7): 545-548. doi: 10.13201/j.issn.2096-7993.2022.07.013

    [15]

    Tan TY, Pang KP, Goh HK, et al. Castleman's disease of the neck: a description of four cases on contrast-enhanced CT[J]. Br J Radiol, 2004, 77(915): 253-256. doi: 10.1259/bjr/52051980

    [16]

    Kwon S, Lee KS, Ahn S, et al. Thoracic Castleman disease: computed tomography and clinical findings[J]. J Comput Assist Tomogr, 2013, 37(1): 1-8. doi: 10.1097/RCT.0b013e318270658b

    [17]

    Jiang XH, Song HM, Liu QY, et al. Castleman disease of the neck: CT and MR imaging findings[J]. Eur J Radiol, 2014, 83(11): 2041-2150. doi: 10.1016/j.ejrad.2014.08.013

    [18]

    Park SH, Cho A, Ryu HJ, et al. Profile of vascular markers and CT enhancement of hyaline vascular type Castleman's disease[J]. Microvasc Res, 2022, 142: 104357. doi: 10.1016/j.mvr.2022.104357

    [19]

    Sun X, Du Y, Zhang Y, et al. Unicentric Castleman disease: multidetector computed tomography classification with surgical and pathologic correlation[J]. Quant Imaging Med Surg, 2021, 11(8): 3562-3568. doi: 10.21037/qims-20-1033

    [20]

    何艳萍, 黄伟俊, 陈炯垣, 等. 透明血管型Castleman病的超声特征与鉴别诊断[J]. 中国超声医学杂志, 2022, 38(1): 57-60. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCY202201015.htm

    [21]

    Venkataramana CG, Kini H, Saha D, et al. Histomorphologic Spectrum in Hyaline Vascular Variant of Castleman Disease[J]. J Clin Diagn Res, 2017, 11(8): EC01-EC4.

    [22]

    Nguyen DT, Diamond LW, Hansmann ML, et al. Castleman's disease. Differences in follicular dendritic network in the hyaline vascular and plasma cell variants[J]. Histopathology, 1994, 24(5): 437-443. doi: 10.1111/j.1365-2559.1994.tb00552.x

    [23]

    Li Z, Lan X, Li C, et al. Recurrent PDGFRB mutations in unicentric Castleman disease[J]. Leukemia, 2019, 33(4): 1035-1038.

    [24]

    Ager A. High Endothelial Venules and Other Blood Vessels: Critical Regulators of Lymphoid Organ Development and Function[J]. Front Immunol, 2017, 8: 45.

    [25]

    Ager A, May MJ. Understanding high endothelial venules: Lessons for cancer immunology[J]. Oncoimmunology, 2015, 4(6): e1008791.

    [26]

    Girard JP, Moussion C, Forster R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes[J]. Nat Rev Immunol, 2012, 12(11): 762-773.

  • 加载中
计量
  • 文章访问数:  355
  • 施引文献:  0
出版历程
收稿日期:  2023-12-19
刊出日期:  2024-08-03

返回顶部

目录